Home › Funds › Englebert Financial Advisers, LLC › ELV

Englebert Financial Advisers, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Englebert Financial Advisers, LLC reported holding 1,080 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$418K, representing 0.42% of its reported portfolio and ranking #45 among its reported holdings. Englebert Financial Advisers, LLC has disclosed ELV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.08K sh
Reported value held$417.67K
Portfolio Weight0.42%
First reportedQ4 2025
Last changeNew

How Englebert Financial Advisers, LLC's ELV position evolved

Englebert Financial Advisers, LLC first disclosed a stake in ELV in Q4 2025 at 1,961 shares (US$687K). Across 3 filings, Englebert Financial Advisers, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,080 shares valued at US$418K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.96K $687.43K New
Q1 2026 2.20K $644.64K Add
Q2 2026 1.08K $417.67K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →